Growth Metrics

Vericel (VCEL) Cash & Equivalents (2017 - 2025)

Vericel's Cash & Equivalents history spans 15 years, with the latest figure at $100.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 34.32% year-over-year to $100.1 million; the TTM value through Dec 2025 reached $100.1 million, up 34.32%, while the annual FY2025 figure was $100.1 million, 34.32% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $100.1 million at Vericel, roughly flat from $100.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $100.4 million in Q3 2025 and bottomed at $43.0 million in Q2 2023.
  • The 5-year median for Cash & Equivalents is $61.2 million (2023), against an average of $64.6 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 103.24% in 2021 before it dropped 25.26% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $68.3 million in 2021, then decreased by 25.26% to $51.1 million in 2022, then soared by 35.29% to $69.1 million in 2023, then increased by 7.86% to $74.5 million in 2024, then surged by 34.32% to $100.1 million in 2025.
  • Per Business Quant, the three most recent readings for VCEL's Cash & Equivalents are $100.1 million (Q4 2025), $100.4 million (Q3 2025), and $80.5 million (Q2 2025).